Loading the research desk…

Alaunos Therapeutics, Inc. Common Stock (TCRT)

Publicly reported company facts and saved market data for Alaunos Therapeutics, Inc. Common Stock (TCRT), with sources and as-of times. Saved data is not a live quote.

Company profile

Alaunos Therapeutics is a biotechnology company focused on developing novel therapeutics. The Company's obesity and metabolic disorders program is advancing ALN1003, an oral small-molecule candidate being evaluated as a potential differentiated, non-hormonal, non-incretin approach for obesity- and metabolic-disease-relevant biology.

Company facts

Sector
Health Care
Industry
Pharmaceutical Preparations
Market cap
$7.7M
Incorporated in
United States
Company website
www.alaunos.com
Exchange
NASDAQ

FennEdge notes

Sessions where TCRT appeared in the daily small-cap recap, newest first: opening gap, day change and the SEC filing or halt stored by the close. Facts with source links.

All daily recaps

Saved quote

Saved snapshot, not a real-time quote. Check the market time before relying on it.

Last reported price
$2.02
Reported change
-33.33%
Reported volume
68,447,684
Latest market time

Short interest

Reported short interest
9,736 shares
Settlement date
Source
Nasdaq

Exchange-published short interest for the stated settlement date, not a live short position.

Recent daily sessions

The 10 most recent saved daily sessions, through . Daily OHLC and volume; not real-time.

TCRT daily open, high, low, close and volume
DateOpenHighLowCloseVolume
1.734.321.513.03256,847,300
0.77551.050.771.053,422,602
0.8040.8040.780.785853,809
0.840.8470.780.78189,969
0.740.88960.72010.8381311,738
0.790.8230.7190.7425121,366
0.810.820.77610.795349,397
0.89850.9350.81650.8286,833
0.910.9510.890.9293,767
0.95210.99990.85290.8875125,835

Research this company

FennEdge organizes SEC filings and reported market data. Sign in for additional research and your private trading context.

Sign in to continue